The frequency of SARS-CoV-2-specific CD4+ T cells or CCR6− peripheral Tfh cells in COVID-19 patients has been shown to correlate with virus-neutralizing antibody levels [143,144]. This evidence concerns the gene CD4 and COVID-19.